日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trial

针对严重注射相关感染的传染病和物质使用障碍综合治疗:随机对照HI-SIRI试验方案

Serota, David P; Feaster, Daniel J; Bartholomew, Tyler S; Kapadia, Shashi N; Gooden, Lauren K; Murphy, Sean M; Malik, Subul; Chueng, Teresa A; Hernandez, Salma; Rodriguez, Allan E; Alonso, Elizabeth; Horigian, Viviana E; Walker, Robrina; Matheson, Tim; Moran, Landhing M; Nelson, C Mindy; Parish, Carrigan; Tookes, Hansel E; Rio, Carlos Del; Metsch, Lisa R

Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care

在初级保健中,对阿片类药物使用障碍的污名化仍然是整合基于软件的测量护理的障碍。

Dela Cruz, Adriane M; Karns-Wright, Tara; Kahalnik, Farra; Walker, Robrina; Lanham, Holly J; Potter, Jennifer Sharpe; Trivedi, Madhukar H

Identifying and responding to trial implementation challenges during multisite clinical trials

识别并应对多中心临床试验中试验实施方面的挑战

Greer, Tracy L; Walker, Robrina; Rethorst, Chad D; Northrup, Thomas F; Warden, Diane; Horigian, Viviana E; Silverstein, Meredith; Shores-Wilson, Kathy; Stotts, Angela L; Trivedi, Madhukar H

Differences in pituitary-adrenal reactivity in Black and White men with and without alcohol use disorder

黑人和白人男性(无论是否患有酒精使用障碍)垂体-肾上腺反应性的差异

Price, Julianne L; Frazier, Ian R; Lewis, Ben; Walker, Robrina; Javors, Martin A; Nixon, Sara Jo; Adinoff, Bryon

Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability

在开放标签试点研究中,使用智能手机视频给药监测药物依从性,评估每月一次纳曲酮联合每日一次安非他酮治疗甲基苯丙胺使用障碍的可行性和可接受性

Walker, Robrina; Hillhouse, Maureen; Perrochet, Brian; Sparenborg, Steven; Mooney, Larissa; Ling, Walter

Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data

超越电子健康记录数据的艾滋病毒感染合并物质使用障碍患者30天内再次入院的临床和社会行为预测模型

Nijhawan, Ank E; Metsch, Lisa R; Zhang, Song; Feaster, Daniel J; Gooden, Lauren; Jain, Mamta K; Walker, Robrina; Huffaker, Shannon; Mugavero, Michael J; Jacobs, Petra; Armstrong, Wendy S; Daar, Eric S; Sullivan, Meg; Del Rio, Carlos; Halm, Ethan A

Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study

自评简明相关症状追踪量表(CAST-SR)的心理测量学:来自STRIDE(CTN-0037)研究的结果

Trombello, Joseph M; Killian, Michael O; Liao, Allen; Sanchez, Katherine; Greer, Tracy L; Walker, Robrina; Grannemann, Bruce; Rethorst, Chad D; Carmody, Thomas; Trivedi, Madhukar H

A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder

对简明健康风险追踪自评量表(CHRT-SR,一种自杀倾向测量工具)在兴奋剂使用障碍患者中的心理测量学评估

Sanchez, Katherine; Killian, Michael O; Mayes, Taryn L; Greer, Tracy L; Trombello, Joseph M; Lindblad, Robert; Grannemann, Bruce D; Carmody, Thomas J; Rush, A John; Walker, Robrina; Trivedi, Madhukar H

A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study

采用剂量运动研究的兴奋剂减量干预措施的依从者平均因果效应分析

Carmody, Thomas; Greer, Tracy L; Walker, Robrina; Rethorst, Chad D; Trivedi, Madhukar H

Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial

应对策略作为互联网心理社会治疗的中介因素:来自NIDA CTN多中心有效性试验的二次分析

Lévesque, Annie; Campbell, Aimee N C; Pavlicova, Martina; Hu, Mei-Chen; Walker, Robrina; McClure, Erin A; Ghitza, Udi E; Bailey, Genie; Stitzer, Maxine; Nunes, Edward V